Netrin-1 Expression Is an Independent Prognostic Factor for Poor Patient Survival in Brain Metastases

• Patrick N. Harter,

  Affiliations Edinger Institute, Institute of Neurology, University of Frankfurt am Main, Frankfurt am Main, Germany, German Cancer Consortium (DKTK), Heidelberg, Germany, German Cancer Research Center (DKFZ), Heidelberg, Germany

  ⨯
• Jenny Zinke,

  Affiliation Edinger Institute, Institute of Neurology, University of Frankfurt am Main, Frankfurt am Main, Germany

  ⨯
• Alexander Scholz,

  Affiliation Edinger Institute, Institute of Neurology, University of Frankfurt am Main, Frankfurt am Main, Germany

  ⨯
• Julia Tichy,

  Affiliation Senckenberg Institute of Neurooncology, University of Frankfurt am Main, Frankfurt am Main, Germany

  ⨯
• Cornelia Zachskorn,

  Affiliations Edinger Institute, Institute of Neurology, University of Frankfurt am Main, Frankfurt am Main, Germany, German Cancer Consortium (DKTK), Heidelberg, Germany, German Cancer Research Center (DKFZ), Heidelberg, Germany

  ⨯
• Hans M. Kvasnicka,

  Affiliations German Cancer Consortium (DKTK), Heidelberg, Germany, German Cancer Research Center (DKFZ), Heidelberg, Germany, Senckenberg Institute of Pathology, University of Frankfurt am Main, Frankfurt am Main, Germany

  ⨯
• Benjamin Goeppert,

  Affiliations German Cancer Consortium (DKTK), Heidelberg, Germany, German Cancer Research Center (DKFZ), Heidelberg, Germany, Institute of Pathology, University of Heidelberg, Heidelberg, Germany

  ⨯
• Céline Delloye-Bourgeois,

  Affiliation Apoptosis, Cancer and Development Laboratory, Equipe labellisée ‘La Ligue’, LabEx DEVweCAN, Centre de Cancérologie de Lyon, INSERM U1052-CNRS UMR5286, Université de Lyon, Centre Léon Bérard, Lyon, France

  ⨯
• Elke Hattingen,

  Affiliation Institute of Neuroradiology, University of Frankfurt am Main, Frankfurt am Main, Germany

  ⨯
• Christian Senft,

  Affiliation Department of Neurosurgery, University of Frankfurt am Main, Frankfurt am Main, Germany

  ⨯
• Joachim P. Steinbach,

  Affiliations German Cancer Consortium (DKTK), Heidelberg, Germany, German Cancer Research Center (DKFZ), Heidelberg, Germany, Senckenberg Institute of Neurooncology, University of Frankfurt am Main, Frankfurt am Main, Germany

  ⨯
• Karl H. Plate,

  Affiliations Edinger Institute, Institute of Neurology, University of Frankfurt am Main, Frankfurt am Main, Germany, German Cancer Consortium (DKTK), Heidelberg, Germany, German Cancer Research Center (DKFZ), Heidelberg, Germany

  ⨯
• Patrick Mehlen,

  Affiliation Apoptosis, Cancer and Development Laboratory, Equipe labellisée ‘La Ligue’, LabEx DEVweCAN, Centre de Cancérologie de Lyon, INSERM U1052-CNRS UMR5286, Université de Lyon, Centre Léon Bérard, Lyon, France

  ⨯
• Dorothea Schulte,

  Affiliation Edinger Institute, Institute of Neurology, University of Frankfurt am Main, Frankfurt am Main, Germany

  ⨯
• Michel Mittelbronn

  * E-mail: michel.mittelbronn@kgu.de

  Affiliations Edinger Institute, Institute of Neurology, University of Frankfurt am Main, Frankfurt am Main, Germany, German Cancer Consortium (DKTK), Heidelberg, Germany, German Cancer Research Center (DKFZ), Heidelberg, Germany

  ⨯